V. Plaza Moral

Treatment of Moderate-severe Asthma: An Alternative Strategy to the Guidelines Recommendations.

S. Quirce Gancedo, L. A. Pérez de Llano, V. Plaza Moral, 2020, Archivos de bronconeumologia.

Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study.

J. Wedzicha, J. Vonk, K. Bønnelykke, 2022, The Lancet. Respiratory medicine.

Obsolete anti-pneumococcal vaccination recommendations in the spanish guidelines for the management of asthma (GEMA 4.0): The authors reply.

A. López Viña, A. Gómez-Outes, S. Quirce Gancedo, 2016, Archivos de bronconeumologia.

The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma–COPD Overlap Syndrome

B. Cosío, M. Muñoz-Esquerre, C. Cisneros Serrano, 2022, Journal of asthma and allergy.

SPANISH GUIDELINE ON THE MANAGEMENT OF ASTHMA

A. López Viña, A. Gómez-Outes, S. Quirce Gancedo, 2016, Journal of investigational allergology & clinical immunology.

Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.

B. Cosío, P. Landete, A. Trisan Alonso, 2019, Respiratory medicine.

Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis.

J. Castro‐Rodriguez, L. Nannini, G. Rodrigo, 2009, Respiratory medicine.

[GEMA(4.0). Guidelines for Asthma Management].

V. Plaza Moral, 2015, Archivos de bronconeumologia.

Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial

A. Agustí, R. Faner, G. Casanovas, 2022, European Respiratory Journal.